Mellström B, Bertilsson L, Birgersson C, Göransson M, von Bahr C
Drug Metab Dispos. 1983 Mar-Apr;11(2):115-9.
To enable in vitro characterization of nortriptyline 10-hydroxylase activity of microsomal fractions of human liver, methods for the determination of E- and Z-10-hydroxynortriptyline were developed. High performance liquid chromatography (HPLC) with UV-detection or HPLC separation followed by quantitation by gas chromatography-mass spectrometry were used. The microsomal 10-hydroxylation of nortriptyline was linear to 60 min with a protein concentration of 1 mg x ml-1. In 15 human livers a 5-fold variation in activity was found. The formation of the Z-isomer comprised 13 +/- 3% (mean +/- SD) of the total 10-hydroxylase activity. The 10-hydroxylation was inhibited by debrisoquine, sparteine, propranolol, and encainide. No effect or a stimulation of the activity was seen with p-nitroanisole and acetanilide.
为了能够在体外对人肝脏微粒体部分的去甲替林10 -羟化酶活性进行表征,开发了测定E -和Z - 10 -羟基去甲替林的方法。使用了配备紫外检测的高效液相色谱(HPLC)或HPLC分离后通过气相色谱 - 质谱法定量的方法。去甲替林的微粒体10 -羟化在蛋白质浓度为1 mg x ml-1时,60分钟内呈线性。在15个人的肝脏中发现活性有5倍的差异。Z -异构体的形成占总10 -羟化酶活性的13±3%(平均值±标准差)。10 -羟化受到布地喹啉、司巴丁、普萘洛尔和恩卡胺的抑制。对硝基苯甲醚和乙酰苯胺对该活性无影响或有刺激作用。